Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with Mirati Therapeutics

Following its $4.8 billion acquisition of local biotech Mirati Therapeutics, Bristol Myers Squibb is laying off a majority of the San Diego company's workforce over the next year.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...